File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Advances in Devices for Cardiac Resynchronization in Heart Failure

TitleAdvances in Devices for Cardiac Resynchronization in Heart Failure
Authors
KeywordsHeart failure
Pacing
Issue Date2003
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1383-875X
Citation
4th International Symposium on Interventional Electrophysiology in the Management of Cardiac Arrhythmias, Newport, Rhode Island, 26-28 September 2003. In Journal Of Interventional Cardiac Electrophysiology, 2003, v. 9 n. 2, p. 167-181 How to Cite?
AbstractPatients with advanced heart failure have a high mortality and morbidity despite medical therapy. Depending on the underlying heart disease and severity of heart failure, 3.7 to 52.8% of patients have a QRS complex ≥120 ms who may have interventricular and intraventricular dyssynchrony correctible by cardiac resynchronization therapy (CRT). The latter is usually achieved with biventiricular pacing, with the left ventricular lead placed in a tributary of the coronary sinus (CS), with a reported success rate between 88-92%. The technical advances for implantation include preformed guide sheaths to canulate the CS, over the wire leads with passive fixation mechanism, and surgical placement methods. Device-specific CRT features include optimizing heart failure through ensurance of a high percentage of pacing, heart failure monitoring, atrioventricular and interventricular timing, and avoiding double ventricular sensing. Furthermore, arrhythmic co-morbidities of heart failure such as atrial fibrillation and ventricular tachyarrhythmias can also be managed. Recent prospective trials suggest that there is a 30% reduction in heart failure hospitalization with CRT, and preliminary results suggest a survival benefit with CRT and implantable cardioverter defibrillator over optimal medical therapy.
Persistent Identifierhttp://hdl.handle.net/10722/77690
ISSN
2023 Impact Factor: 2.1
2023 SCImago Journal Rankings: 0.767
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLau, CPen_HK
dc.contributor.authorBarold, Sen_HK
dc.contributor.authorTse, HFen_HK
dc.contributor.authorLee, KLFen_HK
dc.contributor.authorChan, HWen_HK
dc.contributor.authorFan, Ken_HK
dc.contributor.authorChau, Een_HK
dc.contributor.authorYu, CMen_HK
dc.date.accessioned2010-09-06T07:34:39Z-
dc.date.available2010-09-06T07:34:39Z-
dc.date.issued2003en_HK
dc.identifier.citation4th International Symposium on Interventional Electrophysiology in the Management of Cardiac Arrhythmias, Newport, Rhode Island, 26-28 September 2003. In Journal Of Interventional Cardiac Electrophysiology, 2003, v. 9 n. 2, p. 167-181en_HK
dc.identifier.issn1383-875Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/77690-
dc.description.abstractPatients with advanced heart failure have a high mortality and morbidity despite medical therapy. Depending on the underlying heart disease and severity of heart failure, 3.7 to 52.8% of patients have a QRS complex ≥120 ms who may have interventricular and intraventricular dyssynchrony correctible by cardiac resynchronization therapy (CRT). The latter is usually achieved with biventiricular pacing, with the left ventricular lead placed in a tributary of the coronary sinus (CS), with a reported success rate between 88-92%. The technical advances for implantation include preformed guide sheaths to canulate the CS, over the wire leads with passive fixation mechanism, and surgical placement methods. Device-specific CRT features include optimizing heart failure through ensurance of a high percentage of pacing, heart failure monitoring, atrioventricular and interventricular timing, and avoiding double ventricular sensing. Furthermore, arrhythmic co-morbidities of heart failure such as atrial fibrillation and ventricular tachyarrhythmias can also be managed. Recent prospective trials suggest that there is a 30% reduction in heart failure hospitalization with CRT, and preliminary results suggest a survival benefit with CRT and implantable cardioverter defibrillator over optimal medical therapy.en_HK
dc.languageengen_HK
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1383-875Xen_HK
dc.relation.ispartofJournal of Interventional Cardiac Electrophysiologyen_HK
dc.subjectHeart failureen_HK
dc.subjectPacingen_HK
dc.subject.meshAngiotensin-Converting Enzyme Inhibitors - therapeutic useen_HK
dc.subject.meshArrhythmias, Cardiac - therapyen_HK
dc.subject.meshCardiac Pacing, Artificial - methodsen_HK
dc.subject.meshClinical Trials as Topicen_HK
dc.subject.meshCombined Modality Therapyen_HK
dc.subject.meshDefibrillators, Implantableen_HK
dc.subject.meshHeart Conduction System - pathology - surgeryen_HK
dc.subject.meshHeart Failure - therapyen_HK
dc.subject.meshHeart Ventricles - pathology - surgeryen_HK
dc.subject.meshHumansen_HK
dc.subject.meshPacemaker, Artificialen_HK
dc.titleAdvances in Devices for Cardiac Resynchronization in Heart Failureen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1045-3873&volume=9&issue=2&spage=167&epage=81&date=2003&atitle=Advances+in+devices+for+cardiac+resynchronization+in+heart+failure.en_HK
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_HK
dc.identifier.emailChan, HW:hwchan@cs.hku.hken_HK
dc.identifier.authorityTse, HF=rp00428en_HK
dc.identifier.authorityChan, HW=rp00091en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1023/A:1026365006526en_HK
dc.identifier.pmid14574029-
dc.identifier.scopuseid_2-s2.0-0242680368en_HK
dc.identifier.hkuros88016en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0242680368&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume9en_HK
dc.identifier.issue2en_HK
dc.identifier.spage167en_HK
dc.identifier.epage181en_HK
dc.identifier.isiWOS:000186042400013-
dc.publisher.placeUnited Statesen_HK
dc.description.other4th International Symposium on Interventional Electrophysiology in the Management of Cardiac Arrhythmias, Newport, Rhode Island, 26-28 September 2003. In Journal Of Interventional Cardiac Electrophysiology, 2003, v. 9 n. 2, p. 167-181-
dc.identifier.scopusauthoridLau, CP=7401968501en_HK
dc.identifier.scopusauthoridBarold, S=7101800584en_HK
dc.identifier.scopusauthoridTse, HF=7006070805en_HK
dc.identifier.scopusauthoridLee, KLF=7501505962en_HK
dc.identifier.scopusauthoridChan, HW=24828151400en_HK
dc.identifier.scopusauthoridFan, K=7202978353en_HK
dc.identifier.scopusauthoridChau, E=8081027500en_HK
dc.identifier.scopusauthoridYu, CM=7404976646en_HK
dc.identifier.issnl1383-875X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats